Advisors Asset Management, Inc. Invitae Corp Transaction History

Advisors Asset Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	SELL	$1.9 - $8.63 $5,563 - $25,268	-2,928 Reduced 36.22%	5,157 $13,000
Q2 2022 Aug 08, 2022	SELL	$2.13 - $9.01 $1,537 - $6,505	-722 Reduced 8.2%	8,085 $20,000
Q1 2022 May 17, 2022	SELL	$6.28 - $15.59 $11,090 - $27,531	-1,766 Reduced 16.7%	8,807 $70,000
Q4 2021 Feb 15, 2022	BUY	$14.7 - $28.67 $58,359 - $113,819	3,970 Added 60.12%	10,573 $161,000
Q3 2021 Nov 12, 2021	BUY	$24.31 - $33.6 $42,542 - $58,800	1,750 Added 36.06%	6,603 $188,000

Q2 2021 Jul 30, 2021	BUY	$26.09 - $40.4 $126,614 - $196,061	4,853 New	4,853 $164,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisors Asset Management, Inc. with notifications on news.